Joakim Karlsson obtained his PhD in Bioinformatics in 2019 from the lab of cancer genome expert Professor Erik Larsson (Lekholm). His thesis was awarded ‘Thesis of the Year Award at the Institute of Biomedicine’. In it were three papers [1, 2, 4] with Prof Nilsson as senior author. After the PhD defence, Dr Karlsson moved to Sahlgrenska Cancer Center to join the Nilsson lab, and later also to Perth. Joakim has an impressive skillset in bioinformatics which has already resulted in over a dozen papers included in journals like Nature Genetics , Circulation and Nature Communication [1, 2]. He is the lead author of the recent paper on molecular profiling of driver events in metastatic uveal melanoma  and is also currently involved in biomarker discoveries in the PEMDAC  and SCANDIUM trials for patients with metastatic uveal melanoma. Since January 2021, he has worked as a postdoc in the Melanoma Discovery Lab at the Perkins.
Most important publications:
- Karlsson J., L.M. Nilsson, et al and J.A. Nilsson, Molecular profiling of driver events in metastatic uveal melanoma, Nat Commun, 2020. 11(1): p. 1894.
- Ny, L., Jespersen, H., Karlsson J. et al The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma. Nature commun, 2021, epub.
- Bagge*, R.O., A. Demir*, J. Karlsson*, B et al and J.A. Nilsson, Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown Primary, JCO Precis Oncol, 2018. 2 *Shared first
- Hofving*, T., J. Karlsson*, O. Nilsson, and J.A. Nilsson, H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines, Nat Genet, 2019. 51(10): p. 1426-1427. *Shared first